Long-Term Intracranial Progression-Free Survival in Lung Cancer Brain Metastases Extended Beyond 50 Months with Gubenxiaoyi Formula (GBXY): A Groundbreaking Case Study
Background: The prevalence of brain metastases (BM) in lung cancer patients is notably high and is associated with poor prognoses. The efficacy of standard treatment regimens in improving intracranial progression-free survival (IPFS) for lung cancer BM is markedly limited. While traditional Chinese...
Saved in:
Main Authors: | Zhengzheng Yang, Haiming Li, Lei Chen, Shujiao Li, Dong Chen, Taicheng Lu, Tongjing Ding, Ruiyang Han, Peiyu Cheng, Xiaomin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354241313334 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patricia Bath—The Woman of Many Groundbreaking Firsts in Ophthalmology
by: Sai T. Gopalakrishnan, et al.
Published: (2024-12-01) -
Groundbreaking Technologies and the Biocontrol of Fungal Vascular Plant Pathogens
by: Carmen Gómez-Lama Cabanás, et al.
Published: (2025-01-01) -
Revolutionizing Andrology: The Advent of the Global Andrology Forum, a Groundbreaking Initiative
by: Germar-Michael Pinggera, et al.
Published: (2025-01-01) -
Tribute to Michel E. Safar (1937–2024): A Groundbreaker in the Concept of Hypertension
by: Patrick Lacolley, et al.
Published: (2024-08-01) -
Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation
by: Eva N. Hamulyák, et al.
Published: (2025-02-01)